위샘암종에서 HER2 유전자의 변이 빈도: 면역조직화학염색과 자동화 은제자리부합법 및 형광제자리부합법과의 비교
HER2Status in Gastric Adenocarcinomas Assessed by Immunohistochemistry, Automated Silver-Enhanced In Situ Hybridization and Fluorescence In SituHybridization
김애리, 배정민, 김세원, 구미진, 배영경,
소속 상세정보
김애리 ( Kim Ae-Ri )
영남대학교 의과대학 병리학교실
배정민 ( Bae Jung-Min )
영남대학교 의과대학 외과학교실
김세원 ( Kim Se-Won )
영남대학교 의과대학 외과학교실
구미진 ( Gu Mi-Jin )
대구파티마병원 병리과
배영경 ( Bae Young-Kyung )
영남대학교 의과대학 병리학교실
KMID : 0357920100440050493
Abstract
Background : Recently, many studies have focused on human epidermal growth factor receptor 2 (HER2) status in gastric cancer due to HER2-targeted therapy using trastuzumab. We investigated HER2 overexpression and amplification and their concordance rate in Korean gastric adenocarcinomas.
Methods : Tissue microarrays were constructed with 232 gastric adenocarcinoma samples. We performed immunohistochemistry (IHC), silver-enhanced in situ hybridization (SISH) and fluorescence in situ hybridization (FISH) for HER2.
Results : IHC was negative in 94.8% (218/232), equivocal in 1.7% (4/232) and positive in 3.5% (8/232) of cases. HER2 protein expression was heterogeneous in 75% (9/12) of IHC 2+/3+ cancers. Gene amplification was observed in 6.5% (15/230) by SISH and the same 15 cases were also FISH-positive. We observed HER2 amplification in 1.4%, 27.3%, 25%, and 100% of IHC 0, 1+, 2+, and 3+ gastric adenocarcinomas, respectively. The concordance rate between IHC and SISH results was 95.7%.
Conclusions : HER2 overexpression and amplification were less frequent in gastric adenocarcinomas than breast carcinomas. Compared to breast carcinoma, (1) there may be IHC-negative but gene amplification-positive cases for HER2 and (2) frequent intratumoral heterogeneity of IHC for HER2 in gastric adenocarcinomas.
키워드
Stomach neoplasms; HER2; human; In situ hybridization; fluorescence; Silver; In situ hybridization
원문 및 링크아웃 정보
등재저널 정보